British drug to be first ever cannabis epilepsy medicine to gain regulatory approval

A cannabis-derived treatment for severe epilepsy in children that was discovered and developed in Britain will be the first medication of its kind to gain regulatory approval when US authorities give it the green light on Wednesday.

Epidiolex is the brainchild of British physician Dr Geoffrey Guy, who founded GW Pharmaceuticals, the publicly-listed company behind the drug, in 1998 in the hope of developing compounds found in the cannabis plant into regulated medications.

The drug made from the marijuana plant aced final stage clinical trials two years ago and was so effective in helping children with Lennox-Gastaut syndrome and Dravet syndrome – two extremely severe forms of epilepsy –

READ THE FULL ARTICLE BELOW

Source: British drug to be first ever cannabis epilepsy medicine to gain regulatory approval

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.